Jiangsu Senxuan Pharmaceutical

Jiangsu Senxuan Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, production, and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fine chemicals. The company is a major global supplier of intermediates for high-volume drugs such as gabapentin and pregabalin, focusing primarily on the central nervous system and anti-viral therapeutic areas. Senxuan operates multiple large-scale manufacturing bases and maintains a strong presence in the international market, exporting products to Europe, North America, and Southeast Asia. As a publicly traded entity on the Beijing Stock Exchange, it provides CDMO services to global pharmaceutical partners while maintaining its own portfolio of generic APIs and specialty chemicals. The company is recognized for its expertise in complex chemical synthesis and high-pressure hydrogenation processes.